Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexamethasone versus inhaled N-acetylcysteine plus intravenous dexamethasone for neonatal respiratory distress syndrome
IRCT2016101917413N21Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone and acetylcysteine in respiratory distress syndrome (RDS) (2 arms), sponsored by Islamic Azad University. Started May 2015; status: completed.
02
Drugs
dexamethasoneacetylcysteine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT2016101917413N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016101917413N21.